Search

everythinglearnresearchcommunity

for

Search:↓

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Redheaded people may have evolved to efficiently make vitamin D in areas with less sunlight.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

The transscrotal testosterone patch normalizes hormone levels in men with AIDS and weight loss but does not improve weight, body mass, or quality of life.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Dogs with sex hormone imbalances may not drink or pee a lot but often lose hair on their body and can have reproductive system issues.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Certain hormone treatments can improve acne and related conditions in women.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.